Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Sfakianos

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Translational Andrology and Urology|June 22, 2018
Dealing with perioperative antiplatelet treatment for transurethral resection of the bladder: primum non nocereFrançois Audenet, John P Sfakianos
Translational Andrology and Urology|November 30, 2017
Psychosocial impact of penile carcinomaFrançois Audenet, John P Sfakianos
Bladder Cancer (Amsterdam, Netherlands)|November 21, 2017
Evidence of Atypical Recurrences After Robot-Assisted Radical Cystectomy: A Comprehensive Review of the LiteratureFrançois Audenet, John P Sfakianos
The Journal of Urology|February 9, 2026
Circulating Tumor DNA in Bladder Cancer: A New Treatment Paradigm?Christopher B Anderson, John P Sfakianos
The Urologic Clinics of North America|April 18, 2015
Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer: bridging the gap between evidence and practiceJohn P Sfakianos, Matthew D Galsky
Urology|June 1, 2024
Reply to Editorial Comment on "Thromboembolic Events After Robotic Radical Cystectomy: A Comparative Analysis of Extended and Limited Prophylaxis"Jordan M Rich, John P Sfakianos
Urologic Oncology|March 26, 2018
The evolution of bladder cancer genomics: What have we learned and how can we use it?François Audenet, Kyrollis Attalla, John P Sfakianos
Translational Andrology and Urology|August 9, 2019
Role of heat shock proteins in bladder cancer: potential biomarkers for treatment response and oncological prognosisJorge Daza, Zeynep Gul, John P Sfakianos
Cancer Treatment and Research|September 1, 2018
Current Role of Checkpoint Inhibitors in Urologic CancersKyrollis Attalla, John P Sfakianos, Matthew D Galsky
Cancers|November 13, 2021
Tumor Heterogeneity and Consequences for Bladder Cancer TreatmentEtienne Lavallee, John P Sfakianos, David J Mulholland
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Translational Andrology and Urology|June 22, 2018
Dealing with perioperative antiplatelet treatment for transurethral resection of the bladder: primum non nocereFrançois Audenet, John P Sfakianos
Translational Andrology and Urology|November 30, 2017
Psychosocial impact of penile carcinomaFrançois Audenet, John P Sfakianos
Bladder Cancer (Amsterdam, Netherlands)|November 21, 2017
Evidence of Atypical Recurrences After Robot-Assisted Radical Cystectomy: A Comprehensive Review of the LiteratureFrançois Audenet, John P Sfakianos
The Journal of Urology|February 9, 2026
Circulating Tumor DNA in Bladder Cancer: A New Treatment Paradigm?Christopher B Anderson, John P Sfakianos
The Urologic Clinics of North America|April 18, 2015
Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer: bridging the gap between evidence and practiceJohn P Sfakianos, Matthew D Galsky
Urology|June 1, 2024
Reply to Editorial Comment on "Thromboembolic Events After Robotic Radical Cystectomy: A Comparative Analysis of Extended and Limited Prophylaxis"Jordan M Rich, John P Sfakianos
Urologic Oncology|March 26, 2018
The evolution of bladder cancer genomics: What have we learned and how can we use it?François Audenet, Kyrollis Attalla, John P Sfakianos
Translational Andrology and Urology|August 9, 2019
Role of heat shock proteins in bladder cancer: potential biomarkers for treatment response and oncological prognosisJorge Daza, Zeynep Gul, John P Sfakianos
Cancer Treatment and Research|September 1, 2018
Current Role of Checkpoint Inhibitors in Urologic CancersKyrollis Attalla, John P Sfakianos, Matthew D Galsky
Cancers|November 13, 2021
Tumor Heterogeneity and Consequences for Bladder Cancer TreatmentEtienne Lavallee, John P Sfakianos, David J Mulholland
Pageof 20